Law360, New York (August 07, 2009) -- The Federal Trade Commission has issued a second request to Watson Pharmaceuticals Inc. for more information regarding its proposed merger with generics maker Arrow Group.
Watson announced in June that it would buy Arrow for $1.75 billion in cash and stock. In a statement Thursday, Watson said it would cooperate with the FTC and that...
